Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: d. matt who wrote (2537)	2/25/1998 9:50:00 PM
From: Bill Wexler	Read Replies (1) \| Respond to of 7041

<<what is the significance of being an assignee?>> It simply means that you (as the assignee) have all rights to the patent and the beneftits derived from it. <<who is the tx financial advisor paid in stock.>> Just about anyone associated with this scam has been paid in stock. Most notably: Cappy McGarr and Jeff Opedyke. <<lastly, with $8-9 in cash, do you think it can be shorted here(what's franchise value?>> Actual cash on hand is closer to $4-5 a share (with nearly 13 million fully-diluted shares). Yes, this company is one of the most compelling shorts I have seen in a long time. The "debate" about Vasomax is a red herring. This company has nothing.